Filippo Mocciaro

机构：Azienda di Rilievo Nazionale ed Alta Specializzazione · ORCID：0000-0002-4389-0643

发表论文 292 篇 · 总被引 2240 次 · h-index 28

代表论文

• Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodology (2022 · Digestive and Liver Disease · 被引 45)
• Use of biologics for the management of Crohn's disease: IG-IBD clinical guidelines based on the GRADE methodology (2023 · Digestive and Liver Disease · 被引 32)
• EUS-guided biliary drainage with LAMS for distal malignant biliary obstruction when ERCP fails: single-center retrospective study and maldeployment management (2021 · Surgical Endoscopy · 被引 31)
• Ustekinumab is a promising option for the treatment of postoperative recurrence of Crohn's disease (2023 · Journal of Gastroenterology and Hepatology · 被引 21)
• Vedolizumab may be an effective option for the treatment of postoperative recurrence of Crohn's disease (2021 · Digestive and Liver Disease · 被引 15)
• Incident Colorectal Cancer in Inflammatory Bowel Disease (2022 · Cancers · 被引 12)